DOCSLIB.ORG

Actero Pharma Pvt. Ltd. Draft Eia Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Actero Pharma Pvt. Ltd. Draft Eia Report ACTERO PHARMA PVT. LTD. SY.NO. 407 (PART) AND 411, VELIMINEDU VILLAGE, CHITYAL MANDAL, NALGONDA DISTRICT, TELANGANA DRAFT EIA REPORT 1. ENVIRONMENTAL IMPACT ASSESSMENT 2. ENVIRONMENT MANAGEMENT PLAN 3. COMPLIANCE OF TERMS OF REFERENCE 4. ANNEXURES Project No. 0118‐21‐03 January 2018 M/s. Actero Pharma Pvt. Ltd. STUDIES AND DOCUMENTATION BY C/o. Hetero Drugs Limited TEAM Labs and Consultants Plot No: 7‐2‐A2 Hetero Corp, Industrial Estate, B‐115‐117 & 509, Annapurna Block, Sanathnagar, Hyderabad‐500018 Aditya Enclave, Ameerpet, Phone: 040‐23704923/23704924 Hyderabad‐500 038. E‐mail: [email protected]; Phone: 040‐23748 555/23748616, [email protected] Telefax: 040‐23748666 SUBMITTED TO TELANGANA STATE POLLUTION CONTROL BOARD, REGIONAL OFFICE, NALGONDA ACTERO PHARMA PVT. LTD. SY.NO. 407 (PART) AND 411, VELIMINEDU VILLAGE, CHITYAL MANDAL, NALGONDA DISTRICT, TELANGANA 1. ENVIRONMENTAL IMPACT ASSESSMENT REPORT Project No. 0118‐21‐03 January 2018 M/s. Actero Pharma Pvt. Ltd. STUDIES AND DOCUMENTATION BY C/o. Hetero Drugs Limited TEAM Labs and Consultants Plot No: 7‐2‐A2 Hetero Corp, Industrial Estate, B‐115‐117 & 509, Annapurna Block, Sanathnagar, Hyderabad‐500018 Aditya Enclave, Ameerpet, Phone: 040‐23704923/23704924 Hyderabad‐500 038. E‐mail: [email protected]; Phone: 040‐23748 555/23748616, [email protected] Telefax: 040‐23748666 SUBMITTED TO TELANGANA STATE POLLUTION CONTROL BOARD, REGIONAL OFFICE, NALGONDA Actero Pharma Pvt. Ltd., Contents CONTENTS Section Description Page No. 1.0 Introduction of The Project 1-1 1.1 Product Profile 1-3 1.2 Technology 1-4 1.3 Plant Location & Layout 1-4 1.4 Scope of EIA Studies 1-8 2 Process Description and Pollution control Facilities 2-1 2.1 Process Description 2-2 2.1.1 Process Description of Abiraterone Acetate 2-2 2.1.2 Process Description of Afatinib 2-6 2.1.3 Process Description of Anastrazole 2-12 2.1.4 Process Description of Bicalutamide 2-15 2.1.5 Process Description of Bendamustine HCl 2-17 2.1.6 Process Description of Bexarotene 2-20 2.1.7 Process Description of Bosutinib 2-23 2.1.8 Process Description of Capecitabine 2-28 2.1.9 Process Description of Carfilzomib 2-30 2.1.10 Process Description of Ceritinib 2-34 2.1.11 Process Description of Cyclophosphamide 2-37 2.1.12 Process Description of Dasatinib 2-39 2.1.13 Process Description of Docetaxel 2-41 2.1.14 Process Description of Enzalutamide 2-43 2.1.15 Process Description of Erlotinib HCl 2-48 2.1.16 Process Description of Gefitinib 2-50 2.1.17 Process Description of Gemcitabine HCl 2-52 2.1.18 Process Description of Ibrutinib 2-55 2.1.19 Process Description of Imatinib Mesylate 2-60 2.1.20 Process Description of Lapatanib 2-63 2.1.21 Process Description of Lenvatinib 2-66 2.1.22 Process Description of Olaparib 2-67 2.1.23 Process Description of Palbociclib 2-72 2.1.24 Process Description of Pazopanib 2-76 2.1.25 Process Description of Sorefinib 2-78 2.1.26 Process Description of Sunitinib 2-80 2.1.27 Process Description of Tamoxifene 2-82 2.2 Utilities 2-84 2.3 Water Requirement 2-84 2.4 Pollution Control Facilities 2-86 2.4.1 Water Pollution 2-86 2.4.1.1 Process Description and Technical Specification of Effluent Treatment System 2-91 2.4.2 Air Pollution 2-97 2.4.2.1 Emissions from Utilities 2-98 2.4.2.2 Emissions from Process 2-99 2.4.2.3 Diffuse Emissions 2-101 2.4.2.4 Fugitive Emissions 2-101 Actero Pharma Pvt. Ltd., Contents 2.4.3 Solvent Use and Recycle 2-102 2.4.4 Solid Waste 2-109 2.4.5 Noise Pollution 2-115 3.0 Baseline Environmental Status 3-1 3.1 Introduction 3-1 3.2 Land Environment 3-1 3.2.1 Physiography 3-1 3.2.2 Geology 3-5 3.2.3 Hydrogeology 3-7 3.2.4 Soils 3-9 3.3 Water environment 3-14 3.3.1 Surface Water Resources 3-14 3.3.1.1 Surface water Quality 3-14 3.3.1.2 Ground Water resources 3-15 3.3.1.3 Quality Of Ground Water 3-15 3.4 Air environment 3-20 3.4.1 Meteorology 3-20 3.4.2 Meteorological Station at Plant Site 3-23 3.4.3 Ambient air quality 3-26 3.4.4 Scope of field study 3-28 3.4.5 Description of sampling locations 3-30 3.4.6 Ambient Air Quality Status 3-32 3.4.7 Noise environment 3-34 3.4.8 Traffic Study 3-36 3.5 Socio economic environment 3-37 3.6 Demography 3-37 3.6.1 Population Distribution 3-38 3.6.1.1 Literacy 3-39 3.6.1.2 Employment/Occupation 3-39 3.6.1.3 Living standards and Infrastructure 3-42 3.6.2 Land Utilization 3-44 3.6.3 Project Economy 3-44 3.7 Flora and Fauna 3-45 4 Identification of Impacts 4.1 Identification of Impacts 4-1 4.1.1 Impact Networks 4-1 4.2 Prediction of Impacts 4-8 4.2.1 Air Environment 4-8 4.2.1.1 Details of Mathematical Modeling 4-9 4.2.1.2 Utility Emissions 4-12 4.2.1.3 Air Quality Predictions 4-13 4.2.1.4 Prediction of Concentration of Solvents in the Indoor Environment Due to 4-21 Solvent Loss and Fugitive Emissions 4.2.2 Water Environment 4-22 4.2.3 Noise Environment 4-23 4.2.3.1 Prediction of Impact on Noise Quality 4-23 4.2.4 Land Environment 4-24 4.2.5 Biological Environment 4-25 Actero Pharma Pvt. Ltd., Contents 4.2.6 Socio-economic Environment 4-26 4.2.7 Prediction of Impact on Vehicular Traffic 4-26 5 Analysis of Alternatives 5-1 5.1 Alternative sites 5-1 5.2 Alternative in Process 5-1 5.2.1 Alternatives in Technology 5-2 5.2.2 Alternatives in treatment/mitigation options 5-3 6 Environmental Monitoring 6-1 6.1.1 Introduction 6-1 6.1.2 Objectives 6-1 6.1.3 Methodology 6-1 6.1.4 Ambient Air Quality (AAQ) Monitoring 6-2 6.1.5 Water Quality Monitoring 6-3 6.1.6 Noise Level Monitoring 6-8 6.1.7 Responsibility of Monitoring And Reporting System 6-9 6.1.7.1 Work Zone Monitoring for Hazardous Chemicals 6-10 6.2 Environmental Monitoring Budget 6-10 7 Risk Assessment and Damage Control 7-1 7.0 Introduction 7-1 7.1 Objectives and Scope 7-1 7.2 Project Details 7-2 7.3 Process Description 7-10 7.4 Plant Facilities 7-10 7.4.1 Production Blocks 7-10 7.4.2 Utilities 7-10 7.4.3 Quality Control, R&D Lab 7-11 7.4.4 ETP and Solid Waste storage 7-11 7.4.5 Ware Houses 7-11 7.4.6 Tank Farm Area 7-11 7.4.7 Cylinders Storage Area 7-12 7.4.8 Administrative Office 7-12 7.4.9 House Keeping 7-12 7.4.10 Coal and Ash Storage 7-12 7.4.11 Facility Layout and Design 7-12 7.5 Hazard Analysis and Risk Assessment 7-16 7.5.1 Introduction 7-16 7.5.2 Hazard Identification 7-16 7.5.3 Fire & Explosion Index (F & EI) 7-20 7.5.3.1 Methodology 7-20 7.5.4 Hazard and Operability Study (HAZOP) 7-22 7.5.5 Hazard Factors 7-23 7.5.6 Common Causes of Accidents 7-24 7.6 Maximum Credible Accident and Consequence Analysis (MCACA) 7-25 7.6.1 Methodology 7-26 7.6.2 Identification of Vulnerable Areas 7-26 7.6.3 Representative Accident Scenarios 7-27 7.7 Consequence Analysis 7-28 7.7.1 Release Models and Source strength 7-28 Actero Pharma Pvt. Ltd., Contents 7.7.2 Results of Consequence Analysis 7-30 7.7.2.1 Analysis of Hazardous Scenarios 7-31 7.7.2.1.1 Heat radiation effects 7-31 7.7.2.1.2 Overpressure effects 7-32 7.7.3 Observations 7-32 7.7.4 Recommendations 7-32 7.7.5 Toxic management plan 7-33 7.7.6 Transportation 7-35 7.7.7 Control measures for accidental spillage of chemicals 7-38 7.8 Disaster Management Plan 7-40 7.8.1 Introduction 7-40 7.8.2 Objectives Of Emergency Management Plan (On-Site) 7-41 7.8.3 Scope Of ONSEP 7-42 7.8.4 Methodology Of Developing ONSET 7-42 7.8.5 Element Of ONSITE Emergency Plan 7-42 7.8.5.1 Emergencies Identified 7-436 7.8.5.2 Emergency Organization 7-43 7.8.5.3 Emergency Facilities 7-43 7.8.5.4 Emergency Procedures 7-46 7.8.5.5 Rescue and Rehabilitation 7-47 7.8.5.6 Emergency Responsibilities 7-48 7.8.6 Remedial Action 7-53 7.8.7 Basic Action In Emergencies 7-54 7.8.8 Fire Fighting Operation 7-54 8 Project Benefits 8-1 8.1 Introduction 8-1 8.2 Employment Potential 8-1 8.3 Corporate Social Responsibility 8-1 9 Environment Cost Benefit Analysis 9-1 10 Environment Management Plan 10-1 10.0 Introduction 10-1 10.1 Environment Management Plan 10-2 10.1.1 Construction Phase 10-2 10.1.2 Operation Phase 10-3 10.2 Sources of Pollution from Manufacturing Process 10-3 10.2.1 Water Pollution 10-3 10.2.1.1 Process Description and Technical Specification of Effluent Treatment System 10-5 10.2.2 Air Pollution 10-11 10.2.2.1 Emissions from Utilities 10-11 10.2.2.2 Emissions from Process 10-13 10.2.2.3 Diffuse Emissions 10-15 10.2.2.4 Fugitive Emissions 10-15 10.2.2.5 Odor Management 10-16 10.2.3 Solvent Use and Recycle 10-16 10.2.4 Solid Waste 10-19 10.2.5 Noise Pollution 10-20 10.3 Rainwater Harvesting 10-21 10.4 Occupational Safety and Health 10-24 Actero Pharma Pvt.
Load more

Recommended publications
  • Annual Report 2015-16
    Annual Report 2015-16 Corporate Social Responsibility and Sustainable Initiatives Bharat Dynamics Limited (A Government of India Enterprise) Submitted by: About ASCI Administrative Staff College of India (ASCI) is an institution of national importance established in Hyderabad in 1956 at the initiative of the government of India and Indian Industry. ASCI has pioneered post-experience management training in India. ASCI’s research activities commenced in 1973 with support from Ford Foundation. Over the years ASCI has carved a niche for itself on the strength of its domain expertise, well-researched inputs and management expertise. ASCI regularly assists corporates in several management and sectoral areas through research and consulting activities. About BDL BDL was established in 1970. A high technology multi-disciplinary industry employing about 3200 employees in different categories is having three units : one at Kanchanbagh, Hyderabad, the other at Bhanur village in Patancheru Mandal of Medak District in Telangana State and the third at Visakhapatnam in Andhra Pradesh. The Company is establishing two more new Units at Ibrahimpatnam in Ranga Reddy District in Telangana and the other at Amravati in Maharashtra. BDL is the prime production agency for the guided missiles requirement of the Country, apart from producing other vital and strategic equipment for defence requirement of the Nation. Investigators Dr. Balbir Singh (Team Leader), Dr. Sreerupa Sengupta (Team member), Ms. Srilekha Ravvarapu (Team member) and Mr. Obaid ur Rahman Ghori (Research Associate), ASCI. The report has been conceptualised, designed and edited by Dr. Balbir Singh & Dr. Sreerupa Sengupta. Acknowledgements The investigators would like to acknowledge and thank the help and cooperation received from the following BDL officials- Dr N.
    [Show full text]
  • District Census Handbook, Nalgonda, Part X
    CENSUS 1971 SERIES 2 ANDHRA PRADESH DISTRICT CENSUS HANDBOOK NALGONDA PART X-A VILLAGE & TOWN DIRECTORY PART X-B VILLAGE & TOWN PRIMARY CENSUS ABSTRACT T. VEDANTAM OF THE INDIAN ADMINISTRATIVE SERVICE DIRECTOR OF CENSUS OPERATIONS ANDHRA PRADESH PUBLISHED BY THE GOVERNMENT OF ANDHRA PRADESH 1974 The Jain Mahavira The motif presented on the cover page of the Nalgonda District Census Handbook represents the image of the Jain Mahavira sculptured on a light greenish jade in the famous jain tempte at Kolanpak village at Bhongir taluk in Nalgonda district. At present a large village spreading over 16 Sq. Kms. with a population of 7,075 persens, Kolanpak was a reputed town during the Early and Middle Ages. The place was identified as the Kusasthalapura of Dhananjaya who was defeated by Samudragupta in the 4th century A.D. It later became the second capital of the Kalyani Chalukyas from the 11 th century A.D. Afterwards it passed into the hands of the Cholas during the reign of king Rajendra Chola and then into the hands of the Kakatiyas who came to power in the succeeding centuries. Apart from being a flourishing and prosperous commercial centre, Kolanpak popularly known as Kulpak was a cradle of religions and served as a meeting ground for t"e three important religious faiths of the day, namely Jainism, Saivism and Vaishnavism. All the three faiths thrived side by side in harmony for some time. Traces of the flourishing state of each one of these religions could be seen even today in the remnants of the dilapidated shrines or temples r3presenting the respective religions, existing then in the area.
    [Show full text]
  • Svr Laboratories Pvt.Ltd. Updated Form I
    SVR LABORATORIES PVT.LTD. SY.NO. 238 (Part), 239/A and 239/E, DHOTIGUDEM VILLAGE, POCHAMPALLY MANDAL, NALGONDA DISTRICT, TELANGANA UPDATED FORM I M/s. SVR Laboratories Pvt. Ltd. STUDIES AND DOCUMENTATION BY H.No. 7‐1‐307/14/F/52, TEAM Labs and Consultants Jayaprakash Nagar, Sanathnagar B‐115‐117 & 509, Annapurna Block, Hyderabad, Telangana State Aditya Enclave, Ameerpet, Phone: +91 9010204953 Hyderabad‐500 038. E‐mail: [email protected] Phone: 040‐23748 555/23748616, [email protected] Telefax: 040‐23748666 SUBMITTED TO MINISTRY OF ENVIRONMENT, FORESTS AND CLIMATE CHANGE GOVERNMENT OF INDIA INDIRA PARYAVARAN BHAWAN, JOR BAGH ROAD, NEW DELHI M/s.SVR Laboratories Pvt. Ltd., APPENDIX – I (See Paragraph – 6) FORM I I) Basic Information S.No. Item Details 1 Name of the Project/s M/s. SVR Laboratories Pvt. Ltd., 2 S. No in the Schedule 5 (f) –A category (Synthetic Organic Chemicals) 3 Proposed capacity/area/length/tonnage to Area Existing: 2 Acres be handled/command area/lease Area after Expansion: 6 Acres area/number of wells to be drilled Permitted Production Capacity: 1 TPM Capacity after Expansion: 65 TPM It is proposed to manufacture 10 products at a time on campaign basis out of 30 Products 4 New/Expansion/Modernization Expansion 5 Existing Capacity/Area etc. Existing Capacity: 15 TPM Area Existing: 2 Acres 6 Category of Project i.e 'A' or 'B' “A” 7 Does it attract the general condition? If yes, No please specify 8 Does it attract the Specific condition? If yes, No please specify. 9 Location Plot/Survey/Khasra No.
    [Show full text]
  • Sc/St Backlog -2018)
    PROVISIONAL COMMON LIST OF JUNIOR ASSISTANTS (SC/ST BACKLOG -2018) Local / Application Name of the Father / Qualification Total Marks Percentag Male/ Mobile Date of Birth Caste Non District Full Address of the applicant DISTRICT Remarks Sl.No. Applicant Spouse Name ( Category ) Marks obtained e Female Number Local H.NO 7-65/3/2, VIDYANAGAR, 1 UYKE YOGESHWER BALIRAM 05.08.1991 B.Pharmacy 6025 3490 57.93 M ST Local Adilabad BESIDE SATOSHIMATHA TEMPALE ADILABAD 9533378080 ICHODA, ADILABAD H.NO 1-1-86 NEAR ERODRAM SRI MAMIDI VAISHALI LAXMAN 10.06.1995 B.Sc 2200 1601 72.77 F SC Local Adilabad ADILABAD 9059386119 2 RAM COLONY ADILABAD H.NO 2-104/12, VILL & MDL BALIRAM A VITTAL 15.06.1986 B.Sc 2200 1105 50.23 M ST Local Adilabad ADILABAD 7993792754 3 BHEEMPUR DIST ADILABAD MUKKERA MUKKERA H.NO 4-65 VILL PENDALWADA I TO X BONAFIDES NOT 13.01.1996 B.Sc 2200 1383 62.86 M SC Local Adilabad ADILABAD 9676515592 4 SANTOSH BORRANNA MDL JAINATH ADILABAD SUBMITTED KUMRA ANIL KUMRA KESHAV H.NO 1-11 VILL CHINCHUGHAT, 20.06.1994 BA 1600 679 42.44 M ST Local Adilabad ADILABAD 7013965771 5 KUMAR RAO ADILABAD H.NO 8-29, VILL SHANKAR TANDA I TO IV BONAFIDES NOT 6 JADHAV SATEESH JADHAV BHIKKU 03.05.1992 B.Tech 5200 2962 56.96 M ST Local Adilabad HASNAPUR MDL UTNOOR ADILABAD 9542906066 ADILABAD SUBMITTED T. SARVESHWAR H.NO 2-4-267/1, KOLIPURA I TO III BONAFIDES NOT T.SRINIVAS 12.02.1985 BA 1600 781 48.81 M SC Local Adilabad ADILABAD 9949867303 8 RAO COLONY ADILABAD SUBMITTED MANDA PRAVEEN H.NO 4-106 VILL KONDAPUR MDL SHANKAR 03.08.1989 B.Com 1900 942 49.58 M SC
    [Show full text]